A Registry Study on Serumal Biomarkers About Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting. (ASBA-CABG)

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Status: Enrolling

Conditions: Cardiac Surgery

Treatments: Procedure: A type of operation for coranary heart disease patients.

Study type: Observational

Funder types: Other

Identifiers

NCT04107571

20190924

Details and patient eligibility

About

This is a national registry study to determine the serumal biomarkers for prognosis of adverse events in patients undergoing coronary artery bypass grafting.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Subject undergoing coronary artery bypass grafting;
2. Age is more than 18 and less than 80 years old;
3. Male and non pregnancy female;
4. Subject who understands study requirements and agrees to sign an informed consent from prior to study procedures.

Exclusion criteria

1. Pregnancy female;
2. Participate in other clinical trial in the last 1 month.
3. Subject who doesn't agree to sign an informed consent from prior to study procedures.
4. Subject undergoing repeat CABG, concomitant valve or other cardiac surgery.

Trial design

2,000 participants in 1 patient group

Cohort

Treatment:

Procedure: A type of operation for coranary heart disease patients.